CDC recommends Pfizer or Moderna booster after J&J vaccine
Adults who received an initial J&J COVID-19 vaccine should receive a Pfizer or Moderna booster at least two months later for the best protection, according to a study released yesterday by the Centers for Disease Control and Prevention. The study examined 80,287 emergency department/urgent care visits and 25,244 hospitalizations in 10 states between Dec. 16, 2021, and March 7, 2022, when omicron was the predominant variant, and found adults who received a Pfizer or Moderna booster after the J&J vaccine were better protected than those who received one or two J&J doses.
Related News Articles
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…